Beyond the knockout: using Cre-lox technology to model cancer, neurodegenerative diseases and more
Beyond the Knockout: Using Cre-lox Technology to Model Cancer, Neurodegenerative Diseases and More (5/15/2014)
Cre-lox technology is widely used to create traditional, tissue-specific, and inducible models. The technology also is a powerful tool for creating sophisticated models of specific human cancers and other human diseases.
In this webinar you will learn:
- How Cre-lox technology is being used to model various human cancers, including early malignancy in lung adenocarcinoma, breast cancer and melanoma
- How Cre-lox technology is furthering our understanding of Amyotrophic Lateral Sclerosis (ALS), Parkinson’s Disease and other neurodegenerative disorders
- How Cre-reporter strains can be used to label specific cell populations and in mosaic and lineage tracing analyses
Presenter: Peter Kelmenson, Technical Information Scientist
